Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.7 HKD | -7.05% | -17.10% | -31.38% |
04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.38% | 3.01B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.52% | 21.58B | |
-9.77% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- 9995 Stock
- News RemeGen Co., Ltd.
- Chinese Regulators Grant Conditional Marketing Approval to Remegen's Urothelial Carcinoma Treatment